• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . Identification of a highly conserved neutralizing epitope within the RBD region of diverse SARS-CoV-2 variants

tetano

Editor, Senior Moderator
Nat Commun


. 2024 Jan 29;15(1):842.
doi: 10.1038/s41467-024-45050-3. Identification of a highly conserved neutralizing epitope within the RBD region of diverse SARS-CoV-2 variants

Yanqun Wang[SUP] #[/SUP][SUP] 1 2 3 [/SUP], An Yan[SUP] #[/SUP][SUP] 4 [/SUP], Deyong Song[SUP] #[/SUP][SUP] 5 [/SUP], Maoqin Duan[SUP] #[/SUP][SUP] 6 [/SUP], Chuangchuang Dong[SUP] 5 [/SUP], Jiantao Chen[SUP] 1 [/SUP], Zihe Jiang[SUP] 4 [/SUP], Yuanzhu Gao[SUP] 4 [/SUP], Muding Rao[SUP] 5 [/SUP], Jianxia Feng[SUP] 5 [/SUP], Zhaoyong Zhang[SUP] 1 [/SUP], Ruxi Qi[SUP] 4 [/SUP], Xiaomin Ma[SUP] 4 [/SUP], Hong Liu[SUP] 5 [/SUP], Beibei Yu[SUP] 5 [/SUP], Qiaoping Wang[SUP] 5 [/SUP], Mengqi Zong[SUP] 5 [/SUP], Jie Jiao[SUP] 5 [/SUP], Pingping Xing[SUP] 5 [/SUP], Rongrong Pan[SUP] 5 [/SUP], Dan Li[SUP] 5 [/SUP], Juxue Xiao[SUP] 1 [/SUP], Junbo Sun[SUP] 5 [/SUP], Ying Li[SUP] 5 [/SUP], Linfeng Zhang[SUP] 5 [/SUP], Zhenduo Shen[SUP] 5 [/SUP], Baiping Sun[SUP] 5 [/SUP], Yanyan Zhao[SUP] 5 [/SUP], Lu Zhang[SUP] 7 [/SUP], Jun Dai[SUP] 7 [/SUP], Jingxian Zhao[SUP] 1 [/SUP], Lan Wang[SUP] 8 [/SUP], Changlin Dou[SUP] 9 [/SUP], Zheng Liu[SUP] 10 [/SUP], Jincun Zhao[SUP] 11 12 13 14 [/SUP]



Affiliations
Free PMC article Abstract

The constant emergence of SARS-CoV-2 variants continues to impair the efficacy of existing neutralizing antibodies, especially XBB.1.5 and EG.5, which showed exceptional immune evasion properties. Here, we identify a highly conserved neutralizing epitope targeted by a broad-spectrum neutralizing antibody BA7535, which demonstrates high neutralization potency against not only previous variants, such as Alpha, Beta, Gamma, Delta and Omicron BA.1-BA.5, but also more recently emerged Omicron subvariants, including BF.7, CH.1.1, XBB.1, XBB.1.5, XBB.1.9.1, EG.5. Structural analysis of the Omicron Spike trimer with BA7535-Fab using cryo-EM indicates that BA7535 recognizes a highly conserved cryptic receptor-binding domain (RBD) epitope, avoiding most of the mutational hot spots in RBD. Furthermore, structural simulation based on the interaction of BA7535-Fab/RBD complexes dissects the broadly neutralizing effect of BA7535 against latest variants. Therapeutic and prophylactic treatment with BA7535 alone or in combination with BA7208 protected female mice from the circulating Omicron BA.5 and XBB.1 variant infection, suggesting the highly conserved neutralizing epitope serves as a potential target for developing highly potent therapeutic antibodies and vaccines.


 
Back
Top Bottom